These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10. Poncet J, Hortala L, Busquet M, Guéritte-Voegelein F, Thoret S, Pierré A, Atassi G, Jouin P. Bioorg Med Chem Lett; 1998 Oct 20; 8(20):2855-8. PubMed ID: 9873636 [Abstract] [Full Text] [Related]
30. Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452. Luesch H, Yoshida WY, Moore RE, Paul VJ, Mooberry SL, Corbett TH. J Nat Prod; 2002 Jan 20; 65(1):16-20. PubMed ID: 11809057 [Abstract] [Full Text] [Related]
31. The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog. Mooberry SL, Leal RM, Tinley TL, Luesch H, Moore RE, Corbett TH. Int J Cancer; 2003 Apr 20; 104(4):512-21. PubMed ID: 12584751 [Abstract] [Full Text] [Related]
32. Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actin. Bai R, Verdier-Pinard P, Gangwar S, Stessman CC, McClure KJ, Sausville EA, Pettit GR, Bates RB, Hamel E. Mol Pharmacol; 2001 Mar 20; 59(3):462-9. PubMed ID: 11179440 [Abstract] [Full Text] [Related]
33. Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum. Fennell BJ, Carolan S, Pettit GR, Bell A. J Antimicrob Chemother; 2003 Apr 20; 51(4):833-41. PubMed ID: 12654761 [Abstract] [Full Text] [Related]
34. Interaction of dolastatin 10 with bovine brain tubulin. Ludueña RF, Roach MC, Prasad V, Pettit GR. Biochem Pharmacol; 1992 Feb 04; 43(3):539-43. PubMed ID: 1540211 [Abstract] [Full Text] [Related]
35. Direct photoaffinity labeling by dolastatin 10 of the amino-terminal peptide of beta-tubulin containing cysteine 12. Bai R, Covell DG, Taylor GF, Kepler JA, Copeland TD, Nguyen NY, Pettit GR, Hamel E. J Biol Chem; 2004 Jul 16; 279(29):30731-40. PubMed ID: 15123603 [Abstract] [Full Text] [Related]
36. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification. Kalemkerian GP, Ou X, Adil MR, Rosati R, Khoulani MM, Madan SK, Pettit GR. Cancer Chemother Pharmacol; 1999 Jul 16; 43(6):507-15. PubMed ID: 10321512 [Abstract] [Full Text] [Related]
37. Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity. Bai R, Edler MC, Bonate PL, Copeland TD, Pettit GR, Ludueña RF, Hamel E. Mol Pharmacol; 2009 Jan 16; 75(1):218-26. PubMed ID: 18927208 [Abstract] [Full Text] [Related]
38. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines. Ali MA, Rosati R, Pettit GR, Kalemkerian GP. Anticancer Res; 1998 Jan 16; 18(2A):1021-6. PubMed ID: 9615758 [Abstract] [Full Text] [Related]
39. Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. Jiang JB, Hesson DP, Dusak BA, Dexter DL, Kang GJ, Hamel E. J Med Chem; 1990 Jun 16; 33(6):1721-8. PubMed ID: 2088342 [Abstract] [Full Text] [Related]
40. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis. de Arruda M, Cocchiaro CA, Nelson CM, Grinnell CM, Janssen B, Haupt A, Barlozzari T. Cancer Res; 1995 Jul 15; 55(14):3085-92. PubMed ID: 7606731 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]